Background/Aims: A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) enzymes take part in extracellular matrix (ECM) remodeling which has been shown to contribute to the ovulation and follicular functions. We aimed to compare serum levels of ADAMTS-19 in patients with different fertility situations. Methods: A total of 86 women were enrolled to this cross sectional and case-control study. Four groups were constituted with respect to women’s clinical and hormonal status: group 1, women with premature ovarian failure (POF; n = 21); group 2, women with natural menopause (n = 21); group 3, women with polycystic ovary syndrome (PCOS; n = 22); and group 4, healthy fertile controls. Serum ADAMTS-19 levels and individual characteristics were compared among groups. Results: -ADAMTS-19 levels were found as 36.7 ± 10.2, 40.1 ± 12.6, 46.7 ± 16.1, and 51.0 ± 18.8 ng/mL in POF, fertile, natural menopause, and PCOS groups, respectively (p = 0.012). Especially, ADAMTS-19 levels in the PCOS group were significantly higher than the POF group, as found in dual comparisons (p = 0.010). Conclusions: ADAMTS-19 was found to be higher in PCOS patients than in POF patients. This work provides a novel vantage point for function of ECM within the ovary. ADAMTS-19 may have a potential for being an important marker of ovarian function and oocyte pool.

Keywords:
A Disintegrin and Metalloproteinase with Thrombospondin motifs-19, Fertility, Biomarker, Menopause, polycystic ovary syndrome, premature ovarian failure
1.
Smitz J, Dolmans MM, Donnez J, Fortune JE, Hovatta O, Jewgenow K, Picton HM, Plancha C, Shea LD, Stouffer RL, Telfer EE, Woodruff TK, Zelinski MB: Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update 2010; 16: 395–414.
2.
Curry TE Jr, Smith MF: Impact of extracellular matrix remodeling on ovulation and the folliculo-luteal transition. Semin Reprod Med 2006; 24: 228–241.
3.
Gao S, De Geyter C, Kossowska K, Zhang H: FSH stimulates the expression of the ADAMTS-16 protease in mature human ovarian follicles. Mol Hum Reprod 2007; 13: 465–471.
4.
Wang WM, Ge G, Lim NH, Nagase H, Greenspan DS: TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2. Biochem J 2006; 398: 515–519.
5.
Wayne GJ, Deng SJ, Amour A, Borman S, Matico R, Carter HL, Murphy G: TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4. Biochem J 2007; 282: 20991–20998.
6.
Kelwick R, Desanlis I, Wheeler GN, Edwards DR: The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Genome Biol 2015; 16: 113.
7.
Pyun JA, Kim S, Cha DH, Kwack K: Epistasis between IGF2R and ADAMTS19 polymorphisms associates with premature ovarian failure. Hum Reprod 2013; 28: 3146–3154.
8.
Knauff EA, Franke L, van Es MA, van den Berg LH, van der Schouw YT, Laven JS, et al: Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum Reprod 2009; 24: 2372–2378.
9.
Pyun JA, Kim S, Kwack K: Epistasis between polymorphisms in ACVR2B and ADAMTS19 is associated with premature ovarian failure. Menopause 2015; 22: 212–216.
10.
Porter S, Clark IM, Kevorkian L, Edwards DR: The ADAMTS metalloproteinases. Biochem J 2005; 386: 15–27.
11.
Pyun JA, Kim S, Cha DH, Kwack K: Epistasis between polymorphisms in TSHB and ADAMTS16 is associated with premature ovarian failure. Menopause 2014; 21: 890–895.
12.
Xiao S, Li Y, Li T, Chen M, Xu Y, Wen Y, Zhou C: Evidence for decreased expression of ADAMTS-1 associated with impaired oocyte quality in PCOS patients. J Clin Endocrinol Metab 2014; 99:E1015–E1021.
13.
Shamilova NN, Marchenko LA, Dolgushina NV, Zaletaev DV, Sukhikh GT: The role of genetic and autoimmune factors in premature ovarian failure. J Assist Reprod Genet 2013; 30: 617–622.
14.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19–25.
15.
Menke DB, Koubova J, Page DC: Sexual differentiation of germ cells in XX mouse gonads occurs in an anterior-to-posterior wave. Dev Biol 2003; 262: 303–312.
16.
Russell DL, Brown HM, Dunning KR: ADAMTS proteases in fertility. Matrix Biol 2015; 44–46: 54–63.
17.
Hubmacher D, Apte SS: Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin-1: a novel mechanism influencing microfibril assembly and function. Cell Mol Life Sci. 2011; 68: 3137–3148.
18.
Xie GB, Xu P, Che YN, Xia YJ, Cao YX, Wang WJ, Qiao D, Wu XK, Yi L, Gao Q, Wang Y: Microsatellite polymorphism in the fibrillin 3 gene and susceptibility to PCOS: a case-control study and meta-analysis. Reprod Biomed Online 2013; 26: 168–174.
19.
Kreeger PK, Deck JW, Woodruff TK, Shea LD: The in vitro regulation of ovarian follicle development using alginate-extracellular matrix gels. Biomaterials 2006; 27: 714–723.
20.
Laronda MM, Jakus AE, Whelan KA, Wertheim JA, Shah RN, Woodruff TK: Initiation of puberty in mice following decellularized ovary transplant. Biomaterials 2015; 50: 20–29.
21.
Brown HM, Dunning KR, Robker RL, Pritchard M, Russell DL: Requirement for ADAMTS-1 in extracellular matrix remodeling during ovarian folliculogenesis and lymphangiogenesis. Dev Biol 2006; 300: 699–709.
22.
Russell DL, Doyle KM, Ochsner SA, Sandy JD, Richards JS: Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation. J Biol Chem 2003; 278: 42330–42339.
23.
Brown HM, Dunning KR, Robker RL, Boerboom D, Pritchard M, Lane M, Russell DL: ADAMTS1 cleavage of versican mediates essential structural remodeling of the ovarian follicle and cumulus-oocyte matrix during ovulation in mice. Biol Reprod 2010; 83: 549–557.
24.
Jorge S, Chang S, Barzilai JJ, Leppert P, Segars JH: Mechanical signaling in reproductive tissues: mechanisms and importance. Reprod Sci: 2014; 21: 1093–1107.
25.
Matousek M, Carati C, Gannon B, Brannstrom M: Novel method for intrafollicular pressure measurements in the rat ovary: increased intrafollicular pressure after hCG stimulation. Reproduction 2001; 121: 307–314.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.